A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema

NAUnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
LymphedemaLymphedema of Upper ArmLymphedema, Breast Cancer
Interventions
DEVICE

Crossover Device (PCD or Dayspring - alternate to first group)

Cross over arms after a month of use and a month of washout period

Trial Locations (2)

94024

RECRUITING

PT works, Los Altos

95037

RECRUITING

Ginger-K Lymphedema & Cancer Center, Morgan Hill

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Koya Medical, Inc.

INDUSTRY